Skip to main content

Table 2 Diabetes incidence and screening from 2004–2012 for total population parameters and from 2006–2012 for screening-based parameters

From: Towards a subsiding diabetes epidemic: trends from a large population-based study in Israel

 

2004

2005

2006

2007

2008

2009

2010

2011

2012

Change 2006-2012

Total population a parameters

          

Total at-risk populationa at beginning of year

1891846

1883940

1891392

1907065

1920369

1935712

1955387

1975066

2003464

5.9%

Incident cases

30392

28648

26680

26405

25942

25191

24703

26110

21776

-18.4%

Crude incidence ( 1,000)

16.1

15.2

14.1

13.8

13.5

13

12.6

13.2

10.9

-22.7%

Age-standardized incidence (×1,000)

14.8

14.2

13.3

13.1

12.9

12.6

12.3

13

10.8

-18.8%

Incidence by age group (×1,000)

          

 26-34y

2.2

2

1.9

1.9

1.7

1.7

1.6

1.6

1.6

-15.8%

 35-44y

7

6.7

6.2

6

5.6

5.6

5.1

5.2

4.6

-25.8%

 45-54y

16.2

15.7

15.2

14.3

14.6

14.3

14.5

15.1

13

-14.5%

 55-64y

27.1

25.7

24.2

24

23.7

23.3

23.1

24.1

20

-17.4%

 65-74y

34.1

32.6

29.7

30.4

30.1

28.5

27.7

29.9

23

-22.6%

 75-84y

30.4

29

26.6

27.4

26.4

25.6

24.3

27

21.1

-20.7%

 85y+

21.7

19.6

18.7

19.3

19.1

18.1

17.1

18.1

16

-14.4%

Screening-based parameters

          

Annual screening rateb

  

53.0%

56.4%

60.1%

62.9%

65.3%

66.9%

66.7%

25.8%

Previously-screened (prior 3 years) at-risk populationa

  

1314497

1362188

1411353

1466190

1520518

1562205

1591606

21.1%

Previously-screened incident cases (only those with previous negative screening)

  

20643

20794

21105

20797

20799

22143

17934

-13.1%

Crude previously-screened incidence (×1,000)

  

15.7

15.3

15.0

14.2

13.7

14.2

11.3

-28.2%

Age-standardized previously-screened incidence (×1,000)

  

13.2

12.9

12.8

12.3

12.1

12.6

10.2

-23.0%

Previously-unscreened (prior 3 years) at-risk populationa

  

576895

544877

509016

469522

434869

412861

411858

-28.6%

Previously-unscreened incident cases

  

6037

5611

4837

4394

3904

3967

3842

-36.4%

Crude – previously-unscreened incidence (×1,000)

  

10.5

10.3

9.5

9.4

9.0

9.6

9.3

-10.9%

Age-standardized previously-unscreened incidence (×1,000)

  

14.5

14.9

14.2

14.6

14.2

15.7

15.1

4.0%

  1. aFor Clalit members aged 26 and older.
  2. bPatients, age 26 and older, that received an HbA1c or glucose test in a given year, out of the previously-unscreened (prior 3 years) at-risk population.